01541nam 2200337 450 991068857830332120230628174153.0(CKB)5400000000040481(NjHacI)995400000000040481(EXLCZ)99540000000004048120230628d2019 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierBurden of Respiratory Syncytial Virus Infection in the Young /edited by Bernhard ReschLondon, England :IntechOpen,2019.1 online resource (108 pages)1-83962-252-0 Respiratory syncytial virus (RSV) causes seasonal epidemics during the winter and wet seasons, particularly in young children. Although there is one drug available for prophylaxis, palivizumab, it is indicated for high-risk children only. Therefore a vaccine is urgently needed. This book provides an overview of RSV and discusses its incidence and presentation in different populations, including preterm infants and children with congenital heart disease. It also discusses future strategies for RSV prophylaxis and developments in and barriers to creating a viable vaccine.VirusesViruses.579.2Resch BernhardNjHacINjHaclBOOK9910688578303321Burden of Respiratory Syncytial Virus Infection in the Young3201661UNINA